glucocorticoids,anifrolumab,prednisolone,methotrexate,belimumab,prednisone
astrazeneca,gsk
['thio', 'anifro', 'glucocorticoids', 'prednisone', 'anifrolumab', 'prednisolone', 'belimumab', 'methotrexate', 'rheumatoid,arthritis', 'lupus']
new 2023 sle recommendations key changes, in response to evidence:
- more caution re: steroids
- biologics earlier
- combo therapy (bel or cni/vcs) considered for lupus nephritis
#eular2023 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes journal podcast host. All opinions my own